TCMD Quote, Financials, Valuation and Earnings

Orthofix Medical has a net margin of -4.85% compared to Tactile Systems Technology's net margin of -27.42%. Tactile Systems Technology's return on equity of 7.91% beat Orthofix Medical's return on equity of -27.48%.

Tactile Systems Technology has a consensus price target of $13.00, signalling upside risk potential of 29.87%. On the other hand Orthofix Medical has an analysts' consensus of $22.30 which suggests that it could grow by 105.53%. Given that Orthofix Medical has higher upside potential than Tactile Systems Technology, analysts believe Orthofix Medical is more attractive than Tactile Systems Technology.

Tactile Systems Technology has a beta of 0.952, which suggesting that the stock is 4.824% less volatile than S&P 500. In comparison Orthofix Medical has a beta of 0.796, suggesting its less volatile than the S&P 500 by 20.391%.

Tactile Systems Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Orthofix Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology pays -- of its earnings as a dividend. Orthofix Medical pays out -- of its earnings as a dividend.

Tactile Systems Technology quarterly revenues are $61.3M, which are smaller than Orthofix Medical quarterly revenues of $193.6M. Tactile Systems Technology's net income of -$3M is higher than Orthofix Medical's net income of -$53.1M. Notably, Tactile Systems Technology's price-to-earnings ratio is 15.17x while Orthofix Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology is 0.82x versus 0.52x for Orthofix Medical. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX has a net margin of -4.85% compared to Tactile Systems Technology's net margin of -2201.34%. Tactile Systems Technology's return on equity of 7.91% beat VolitionRX's return on equity of --.

Tactile Systems Technology has a consensus price target of $13.00, signalling upside risk potential of 29.87%. On the other hand VolitionRX has an analysts' consensus of $2.94 which suggests that it could grow by 334.72%. Given that VolitionRX has higher upside potential than Tactile Systems Technology, analysts believe VolitionRX is more attractive than Tactile Systems Technology.

Tactile Systems Technology has a beta of 0.952, which suggesting that the stock is 4.824% less volatile than S&P 500. In comparison VolitionRX has a beta of 1.198, suggesting its more volatile than the S&P 500 by 19.798%.

Tactile Systems Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

Tactile Systems Technology quarterly revenues are $61.3M, which are larger than VolitionRX quarterly revenues of $246.4K. Tactile Systems Technology's net income of -$3M is higher than VolitionRX's net income of -$5.4M. Notably, Tactile Systems Technology's price-to-earnings ratio is 15.17x while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology is 0.82x versus 46.61x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision has a net margin of -4.85% compared to Tactile Systems Technology's net margin of -2828.67%. Tactile Systems Technology's return on equity of 7.91% beat Catheter Precision's return on equity of -137.84%.

Tactile Systems Technology has a consensus price target of $13.00, signalling upside risk potential of 29.87%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 794.06%. Given that Catheter Precision has higher upside potential than Tactile Systems Technology, analysts believe Catheter Precision is more attractive than Tactile Systems Technology.

Tactile Systems Technology has a beta of 0.952, which suggesting that the stock is 4.824% less volatile than S&P 500. In comparison Catheter Precision has a beta of -0.724, suggesting its less volatile than the S&P 500 by 172.434%.

Tactile Systems Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

Tactile Systems Technology quarterly revenues are $61.3M, which are larger than Catheter Precision quarterly revenues of $143K. Tactile Systems Technology's net income of -$3M is higher than Catheter Precision's net income of -$4M. Notably, Tactile Systems Technology's price-to-earnings ratio is 15.17x while Catheter Precision's PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology is 0.82x versus 2.57x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -4.85% compared to Tactile Systems Technology's net margin of 0.18%. Tactile Systems Technology's return on equity of 7.91% beat Xtant Medical Holdings's return on equity of -26.62%.

Tactile Systems Technology has a consensus price target of $13.00, signalling upside risk potential of 29.87%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 182.26%. Given that Xtant Medical Holdings has higher upside potential than Tactile Systems Technology, analysts believe Xtant Medical Holdings is more attractive than Tactile Systems Technology.

Tactile Systems Technology has a beta of 0.952, which suggesting that the stock is 4.824% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.139, suggesting its less volatile than the S&P 500 by 113.918%.

Tactile Systems Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

Tactile Systems Technology quarterly revenues are $61.3M, which are larger than Xtant Medical Holdings quarterly revenues of $32.9M. Tactile Systems Technology's net income of -$3M is lower than Xtant Medical Holdings's net income of $58K. Notably, Tactile Systems Technology's price-to-earnings ratio is 15.17x while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology is 0.82x versus 0.69x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.